Medicamentsen-ligne vous propose les traitements dont vous avez besoin afin de prendre soin de votre santé sexuelle. Avec plus de 6 ans d'expérience et plus de 90.000 clients francophones, nous étions la première clinique fournissant du acheter viagra original en France à vente en ligne et le premier vendeur en ligne de Viagra dans le monde. Pourquoi prendre des risques si vous pouvez être sûr avec Medicamentsen-ligne - Le service auquel vous pouvez faire confiance.

Microsoft word - référence bibliographiques.doc

REFERENCES BIBLIOGRAPHIQUES
M. Feinberg, B. Boulanger, W. Dewe, Ph. Hubert, New advances in method validation and measurement uncertainty aimed at improving the quality of Analytical and Bioanalytical chemistry, 2004, 380, 502 – 514. P. Lantéri, R. Longeray, Chimiométrie: le mariage réussi entre les sciences Analusis, 1996, 24, M17 – M27. J. Goupy, Stratégie de recherche – Définition et objectifs in La méthode des plans d’expériences, Dunod, Paris, France, 1996, Chapitre 1, 1 – 8. J. Goupy, Plans factoriels à deux niveaux d’expériences, Dunod, Paris, France, 1996, Chapitre 1, 9 – 40. A. Albert, Analyses statistiques multivariées , Edition de l’ULg, Liège, 2006. G. Sado, M.-C. Sado, De l’expérimentation à l’assurance de qualité in Les plans d’expériences, AFNOR, Paris, France, 1991. L. Fotsing, Développement et validation de méthodes de dosage des différents constituants de formulations polyvitaminées par électrophorèse capillaire, Thèse présentée en vue de l’obtention du grade de Docteur en Sciences Pharmaceutiques, P. Chiap, Association de la dialyse à la chromatographie liquide pour le dosage automatisé de médicaments dans le plasma, Thèse présentée en vue de l’obtention du grade de Docteur en Sciences Pharmaceutiques, Université de Liège, 1999 – 2000. A.-C. Servais, Séparation et dosage de substances médicamenteuses par électrophorèse capillaire en milieux non aqueux simultanée d’une cyclodextrine et d’un agent d’appariement d’ions, Thèse présentée en vue de l’obtention du grade de Docteur en Sciences Pharmaceutiques, [10] B. Govaerts, L. Simar, Planification expérimentale, Eli-Lilly, Mont-Saint-Guibert, [11] M. Feinberg, Optimisation de la réponse in La validation des méthodes d’analyse – Une approche chimiométrique de l’assurance qualité du laboratoire, Masson, Paris, [12] P. Chiap, B. Boulanger, L Fotsing, Ph. Hubert, J. Crommen, Liquid chromatographic analysis of local anesthesic in human plasma after preparations by on-line dialysis. Optimization by use of experimental design, Chromatographia, 2001, [13] P. J. Schoenmakers in Optimization of chromatographic selectivity, Elsevier, [14] J. P. Bounine, G. Guiochon, L’optimisation multiparamètres assistée par l’ordinateur Analusis, 1984, 12 (4), 175 – 193. [15] P.F. Vanbel, B.L. Tilquin, P.J. Schoenmakers, Criteria for developing rugged high- J. Chromatogr. A, 1995, 697, 3 – 16. [16] P.F. Vanbel, B.L. Tilquin, P.J. Schoenmakers, Criteria for optimizing the separation of target analytes in complex chromatograms, Chemometrics and Intelligent Laboratory Systems, 1996, 35, 67 – 86. [17] P.F. Vanbel, Development of flexible and efficient strategies for optimizing J. Pharm. Biomed. Appl., 1999, 21 (3), 603 – 610. [18] A.C.J.H. Drouen, H.A.H. Billiet, P.J. Schoenmakers, L. de Galan, An improved optimization procedure for the selection of mixed mobile phase in reversed phase Chromatographia, 1982, 16, 48 – 52. [19] W. Dewé, R.D. Marini, P. Chiap, Ph. Hubert, J. Crommen, B. Boulanger, Development of response models for optimising HPLC methods, Chemometrics and Intelligent Laboratory Systems, 2004, 74, 263 – 268. [20] S.N. Deming, Mutliple-criteria optimization, J. Chromatogr. A, 1991, 550, 15 – 25. [21] A. K. Smilde, A. Knevelman, P. M. J. Coenegracht, Introduction of multi- criteria decision making in optimization procedures for high-performance liquid J. Chromatogr., 1986, 369, 1 – 10. [22] M.M.W.B. Hendriks, J.H. De Boer, A.K. Smilde, D.A. Doornbos, Multicriteria Chemometrics and Intelligent Laboratory System, 1992, 16, 175 – [23] D.L. Massart, B.G.M. Vandeginste, L.M.C. Buydens, S. De Jong and P.J. Lewi in Handbook of Chemometrics and Qualimetrics, Part A, Elsevier Science B.V., [24] E.C. Harrington, The desirability function, Ind. Qual. Control, 1965, 21, 494 – 498. [25] G. Derringer, R. Suich, Simultaneous optimization of several response variables, Journal of Quality Technology, 1980, 12 (4) 214 – 219. [26] B. Bourguignon, D.L. Massart, Simultaneous optimization of several chromatographic performance goals using Derringer's desirability function, J. Chromatogr., 1991, 586, 11 – 20. [27] R. D. Marini, P. Chiap, W. Dewé, B. Boulanger, Ph. Hubert, J. Crommen, LC method for the simultaneous determination of R-timolol and other closely related impurities in S-timolol maleate: Optimization by use of an experimental design, J. Sep. Sci., 2003, [28] Y. Guillaume, C. Guinchard, Method to study the separation of eight p- hydroxybenzoic esters by gas chromatography, J. Chromatogr. A, 1996, 727, 93 – 99. [29] M. Jimidar, B. Bourguignon, D. L. Massart, Application of Derringer's desirability function for the selection of optimum separation conditions in capillary zone J. Chromatogr. A, 1996, 740, 109 – 117. [30] P. F. de Aguiar, Y. Vander Heyden, D. L. Massart, Study of different criteria for the selection of a rugged optimum in high performance liquid chromatography Anal. Chim. Acta, 1997, 348, 223 – 235. [31] A. Ceccato, B. Boulanger, P. Chiap, Ph. Hubert, J. Crommen, Simultaneous determination of methylphenobarbital enantiomers and phenobarbital in human plasma by on-line coupling of an achiral precolumn to a chiral liquid chromatographic J. Chromatogr. A, 1998, 819, 143 – 153. [32] R. Gotti, S. Furlanetto, V. Andrisano, V. Cavrini, S. Pinzauti, Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulphate, J. Chromatogr. A, 2000, 875, 411 – 422. [33] Y.L. Loukas, S. Sabbah, G.K.E. Scriba, Method development and validation for the chiral separation of peptides in the presence of cyclodextrins using capillary electrophoresis and experimental design, J. Chromatogr. A, 2001, 931, 141 – 152. [34] E. Van Gyseghem, M. Jimidar, R. Sneyers, D. Redlich, E. Verhoeven, D. L. Massart, Y. Vander Heyden, Selection of reversed-phase liquid chromatographic columns with diverse selectivity towards the potential separation of impurities in drugs, J. Chromatogr. A, 2004, 1042, 69 – 80. [35] D. Mangelings, C. Perrin, D. L. Massart, M. Maftouh, S. Eeltink, W. Th. Kok, P. J. Schoenmakers, Y. Vander Heyden, Optimisation of the chlorthalidone chiral separation by capillary electrochromatography using an achiral stationary phase and cyclodextrin in the mobile phase, Anal. Chim. Acta, 2004, 509, 11 – 19. [36] E. Van Gyseghem, M. Jimidar, R. Sneyers, D. Redlich, E. Verhoeven, D.L. Massart, Y. Vander Heyden, Orthogonality and similarity within silica-based reversed-phased chromatographic systems, J. Chromatogr. A, 2005, 1074, 117 – 131. [37] F. Safa, M.R. Hadjmohammadi, Simultaneous optimization of the resolution and analysis time in micellar liquid chromatography of phenyl thiohydantoin amino acids using Derringer's desirability function, J. Chromatogr. A, 2005, 1078, 42 – 50. [38] J. Caporal-Gauthier, J.M. Nivet, P. Algranti, M. Guilloteau, M. Histe, M. Lallier, J.J. N’guyen-Huu, R. Russoto, Guide de validation analytique, Rapport d’une commission SFSTP, I Méthodologie, S.T.P. Pharma Pratiques, 1992, 2 (4) 205 – 226. [39] Notes explicative III/844/87-FR – Commission des Communautés Européennes, Groupe de travail du Comité des spécialités pharmaceutiques, août 1989. [40] Text on validation of analytical procedures: definitions and terminology (Q2A), Tripartite International Conference on Harmonization (ICH) text, ICH Tech [41] Text on validation of analytical procedures: methodology (Q2B), Tripartite International Conference on Harmonization (ICH) text, ICH Tech coordination, [42] J. Vessman, Selectivity or specificity? Validation of analytical methods from the perspective of an analytical chemist in the pharmaceutical industry, J. Pharm. Biomed. Anal., 1996, 14, 867 – 869. [43] Eurachem guide, The fitness for purpose of analytical methods, A laboratory guide to method validation and related topics, 1st Edition UK, 1998. [44] Food and Drug Administration: International Conference on Harmonization: Guideline on validation of analytical procedures: Definitions and terminology, Fed. Regist., 1995, 60, 11260 – 11262. [45] Food and Drug Administration: International Conference on Harmonization: Guideline on validation of analytical procedures: Methodology, Fed. Regist., 1997, 62, [46] E. Chapuzet, N. Mercier, S Bervoas-Martin, B. Boulanger, P. Chevalier, P. Chiap, D. Granjean, Ph. Hubert, P. Lagorce, M. Lallier, M.C. Laparra, M. Laurentie, J.C. Nivet, Méthodes chromatographiques de dosage dans les milieux biologiques: stratégie de validation, S.T.P. Pharma Pratiques, 1997, 7 (3), 169 – 194. [47] Ph. Hubert, P. Chiap, J. Crommen, B. Boulanger, E. Chapuzet, N. Mercier, S. Bervoas-Martin, P. Chevalier, D. Grandjean, P. Lagorce, M. Lallier, M. C. Laparra, M. Laurentie, J. C. Nivet, The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to Anal. Chim. Acta, 1999, 391, 135 – 148. [48] M. Feinberg, N. Raguènès, Development and application of a standardized validation procedure for food chemistry laboratories, Anal. Chim. Acta, 1999, 391, 239 [49] J. Ermer, Validation in pharmaceutical analysis. Part I: An integrated approach, J. Pharm. Biomed. Anal., 2001, 24, 755 – 767. [50] Ph. Hubert, J.J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P.A. Compagnon, W. Dewé, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, Validation des procédures analytiques quantitatives, Harmonisation des démarches, S.T.P. Pharma Pratiques, 2003, 13 (3), 101 – 138. [51] B. Boulanger, P. Chiap, W. Dewé, J. Crommen, Ph. Hubert, An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progresses and J. Pharm. Biomed. Anal., 2003, 32, 753 – 765. [52] ISO/IEC Standards 5725-2, Accuracy (trueness and precision) of measurement [53] H. Fabre, K.D. Altria, Validating CE methods for pharmaceutical analysis, LC GE Europe, CE currents, May 2001, 1 – 5 (www.lcgceurope.com). [54] R. D. Marini, P. Chiap, B. Boulanger, E. Rozet, S. Rudaz, J. Crommen, Ph. Hubert, LC method for the determination of R-timolol in S-timolol maleate: Validation of its ability to quantify and uncertainty assessment, Talanta, 2006, 68, [55] R. Mee, Estimation of the percentage of a normal distribution lying outside a specified Commun. Statist. Theor. Meth., 17 (1988) 1465 – 1479. [56] ICH Harmonised Tripartite Guideline prepared within the Third International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH), Text on Validation of Analytical Procedures: [57] D. Dadgar, P.E. Burnett, M.G. Choc, K. Gallicano, J.W. Hooper, Application issues in bioanalytical method validation, sample analysis and data reporting, J. Pharm. Anal., 1995, 14, 89 – 97. [58] Y. Vander Heyden, A. Nijhuis, J. Smeyers-Verbeke, B.G.M. Vandeginste, D.L. Massart, Guidance for robustness/ruggedness tests in method validation, J. Pharm. Anal., 2001, 24, 723 – 753. [59] H. Fabre, Robustness testing in liquid chromatography and capillary J. Pharm. Biomed. Anal., 1996, 14, 1125 – 1132. [60] United States Pharmacopeia, 24th Edition, National Formulary 18, United States Pharmacopeial Convention, 2002, Rockville, USA. [61] M. Jimidar, W. Van Ael, M. De Smet, P. Cockaerts, Method validation and robustness testing for enantioselective CE method, LC GC, 2002, 15 (4) 230 – 242. [62] W. Dewé, P. Chiap, Robustesse des méthodes analytiques, Développement, validation et vérification. Cefira, France, Octobre 2001. [63] E. Hund, Y. Vander Heyden, D.L. Massart, J. Smeyers-Verbeke, Derivation of system suitability test limits from a robustness test on an LC assay with complex J. Pharm. Biomed. Anal., 2002, 30, 1197 – 1206. [64] E. Hund, Y. Vander Heyden, M. Haustein, D.L. Massart, J. Smeyers-Verbeke, Robustness testing of a reversed-phase high-performance liquid chromatographic assay: comparison of fractional and asymmetrical factorial designs, J. Chromatogr. A, [65] E. Hund, Y. Vander Heyden, M. Haustein, D.L. Massart, J. Smeyers-Verbeke, Comparison of several criteria to decide on the significance of effects in a robustness test with an asymmetrical factorial design, Anal. Chim. Acta, 2000, 404, [66] C. Perrin, H. Fabre, M. Maftouh, D. L. Massart, Y. Vander Heyden, Robustness testing of chiral separations by capillary electrophoresis using highly-sulfated J. Chromatogr. A, 2003, 1007, 165 – 177. [67] R.D. Marini, B. Boulanger, Y. Vander Heyden, P. Chiap, J. Crommen, Ph. Hubert, Uncertainty assessment from robustness testing applied on an LC assay for R- timolol and other related substances in S-timolol maleate, Anal. Chim. Acta, 2004, [68] G. Box, W. Hunter, J. Hunter, Statistics for experimenters, an introduction to design, data analysis and model building, Wiley, New York, 1978, 306 – 418. [69] E. Morgan, Chemometrics: experimental design in Analytical chemistry by open learning, Wiley, Chichester, 1991, 118 – 188. [70] Y. Vander Heyden, D.L. Massart, Review of the use of robustness and ruggedness in analytical chemistry in A. Smilde, J. de Boer and M. Hendriks (Eds.) Robustness of analytical methods and pharmaceutical technological products, Elsevier, Amsterdam, [71] R.L. Plackett, J.P. Burman, The design of optimum multifactorial experiments, Biometrika, 1946, 33, 305 – 325. [72] Ph. Lowthian, M. Thompson, R. Wood, Use of proficiency tests to assess the comparative performance of analytical methods: the determination of fat in Analyst, 1996, 121, 977 – 982. [73] E. Hund, D.L. Massart, J. Smeyers-Verbeke, Interlaboratory studies in analytical Anal. Chim. Acta, 2000, 423, 145 – 165. [74] International Union of Pure and Applied Chemistry (IUPAC), Analytical Chemistry Division, Commission on General Aspects of Analytical Chemistry (V.1), Project 27/87: Nomenclature for Interlaboratory Studies, Fourth Draft, April 1991. [75] E. A. Maier, Ph. Quevauviller and B. Griepink, Interlaboratory studies as a tool for many purposes: proficiency testing, learning exercises, quality control and Anal. Chim. Acta, 1993, 283, 590 – 599. [76] M. Feinberg, Basics of interlaboratory studies – the trends in the new ISO-5725 Trac - Trends in Anal. Chem., 1995, 14, 450 – 457. [77] ISO/IEC Standards 5725-4, Accuracy (trueness and precision) of measurement methods and results – Part 4: Basic methods for the determination of the trueness of a standard measurement method, Sections 1-6, ISO Geneva, 1994. [78] J. Vial, A. Jardy, Interlaboratory studies: the best way to estimate the characteristic of dispersion of an HPLC method and powerful tool for analytical transfers, Chromatographia, 2001, 53, 141 – S148 [79] Y. Vander Heyden, J. Saevels, E. Roets, J. Hoogmartens, D. Decolin, M. G. Quaglia, W. Van den Bossche, R. Leemans, O. Smeets, F. Van de Vaart, B. Mason, G. C. Taylor, W. Underberg, A. Bult, P. Chiap, J. Crommen, J. De Beer, S. H. Hansen, D. L. Massart, Interlaboratory studies on two high-performance liquid chromatographic assays for tylosin (tartrate), J. Chromatogr. A, 1999, 830, 3 – 28. [80] ISO/IEC Guide 43/1 (E), Proficiency testing by interlaboratory comparisons: Part 1: development and operation of proficiency testing schemes, ISO Geneva, 1997. [81] ISO Guide 35, (E), Certification of reference materials – general and statistical [82] International Standards Organization, General Requirements for the Competence of Calibration and Testing Laboratories, ISO/IEC Guide 17025, ISO, Geneva, 1999. [83] E. A. Maier, Certified reference materials for the quality control of measurements in environmental monitoring, Trends in Anal. Chem., 1991, 10 (10), [84] P. Dehouck, Y. Vander Heyden, J. Smeyers-Verbeke, D. L. Massart, J. Crommen, Ph. Hubert, R. D. Marini, O.S.N.M. Smeets, G. Decristoforo, W. Van de Wauw, J. De Beer, M. G. Quaglia, C. Stella, J.-L. Veuthey, O. Estevenon, A. Van Schepdael, E. Roets, J. Hoogmartens, Determination of uncertainty in analytical measurements: Collaborative study of the analysis of phenoxymethylpenicillin, Anal. Chim. Acta, [85] W.J. Youden, E.H. Steiner, Statistical techniques for the collaborative tests in Statistical manual of the association of official analytical chemists, The Association of Official Analytical Chemists, Arlington, 1975. [86] K.D. Altria, R.C. Harden, M. Hart, J. Hevizi, P.A. Hailey, J.V. Makwana, M.J. Portsmouth, Inter-company cross-validation exercise on capillary electrophoresis, J. Chromatogr., 1993, 641, 147 – 153. [87] K.D. Altria, N.G. Clayton, R.C. Harden, J.V. Makwana, M.J. Portsmouth, Inter- company cross validation exercise on capillary electrophoresis, Chromatographia, [88] B. Mopper, C.J. Sciacchitano, Capillary electrophoresis for regulatory analysis: Is it J. Cap. Electr., 1997, 2, 73 – 76. [89] R. D. Marini, C. Groom, F. R. Doucet, J. Hawari, Y. Bitar, U. Holzgrabe, R. Gotti, J. Schappler, S. Rudaz, J.-L. Veuthey, R. Mol, G. W. Somsen, G. J. De Jong, Ph. Thi Thanh Ha, J. Zhang, A. Van Schepdael, J. Hoogmartens, W. Briône, A. Ceccato, B. Boulanger, D. Mangelings, Y. Vander Heyden, W. Van Ael, I. Jimidar, M. Pedrini, A.-C. Servais, M. Fillet, J. Crommen, E. Rozet, Ph. Hubert, Interlaboratory study of a NACE method for the determination of R-timolol content in S-timolol maleate: Assessment of uncertainty, Electrophoresis, 2006, Sous presse. [90] R. Wood, Food analysis – past, present and future, Valid Analytical Bulletin, National Measurement System, 2005, Issue 32, 4 – 7. [91] S. L. R. Ellison, M. Rosslein, A. Williams, Guide EURACHEM / CITAC « Quantifier l’Incertitude dans les Mesures Analytiques », 2ème Edition, 2000. [92] V. J. Barwick, S. L. R. Ellison, LGC Report, Reference LGC/VAM/1998/052, [93] M. Burns, Current practice in the assessment and control of measurement uncertainty in bio-analytical chemistry, Trac - Trends in Anal. Chem., 2004, Vol. 23, [94] P. Pestiaux, F. Chebana, Ph. Dutot, F. Espinoux, Measurement uncertainty evaluation in oil industry laboratories : The only reasonable way to do it, XXIIth International Metrology Congress 20 -23rd June 2005, Lyon, France. [95] NF X 07 001, “International vocabulary of basic and general terms in metrology [96] L.A. Currie, Nomenclature in evaluation of analytical methods including detection and quantification capabilities (IUPAC Recommendations 1995), Anal. Chim. Acta, [97] BIPM, CEI, FICC, ISO, OIML, UICPA, UIPPA, Guide pour l’expression de l’incertitude de mesure, ISO, Genève 1995. [98] V. J. Barwick, S. L. R. Ellison, VAM Project 3.2.1. Development and Harmonisation of Measurement Uncertainty Principles, Part (d): Protocol for uncertainty evaluation form validation data, LGC Report N° [99] European Co-operation for Accreditation, Lignes directrices d’EA pour l’expression de l’incertitude des résultats d’essai quantitatifs, EA-4/16, Secrétariat, Cofrac, Paris [100] M. Valcárel, A. Ríos, Reliability of analytical information in the XXIst century, Analytica Chimica Acta, 1999, 400, 425 – 432. [101] H. van der Voet, J.A. (Hans) van Rhijn, H. J. van de Wiel, Inter-laboratory, time, and of effective validation, Analytica Chimica Acta, 1999, 391, [102] P. Dehouck, Uncertainty determination in Pharmaceutical Analysis, Thèse présentée en vue de l’obtention du grade de Docteur en Sciences Pharmaceutiques, [103] E. Hund, D. L. Massart, J. Smeyers-Verbecke, Operational definitions of uncertainty, Trac - Trends in Anal. Chem., 2001, Vol. 20 (8), 394 – 406. [104] M. Thompson, Towards a unified model of errors in analytical measurement, Analyst, [105] SSTC/DWTC Project NM/12/23, Norms and Guidelines for the Practical Estimation of Uncertainty in Analytical Measurements, Final report, July 2003, Services Scientifique, Technique et Culturel du Premier Ministre Belge. [106] K. D. Altria, Overview of capillary electrophoresis and capillary J. Chromatogr. A, 1999, 856, 443 – 463. [107] M.-F. Drefuss, P.J.-P. Cardot, Métrologie et analyse du medicament, Analusis, 1999, [108] M. Deleuil, Introduction au procédé d’échantillonnage, Analusis, 1999, 27 (6), 504 – [109] V. J. Barwick, Sources of uncertainty in gas chromatography and high-performance J. Chromatogr. A, 1999, 849, 13 – 33. [110] B. X. Mayer, How to increase precision in capillary electrophoresis, J. Chromatogr. A, [111] B. N. Taylor, C. E. Kuyatt, Guidelines for Evaluating and Expressing the Uncertainty of NIST Measurement Results, NIST Technical Note 1297, National Institute of Standards and Technology, Gaithersburg, MD, 1994. [112] Ellison, V. J. Barwick, Using validation data for ISO measurement uncertainty estimation - Part 1. Principles of an approach using cause and effect analysis, Analyst, [113] A. Maroto, R. Boqué, J. Riu, Evaluating uncertainty in routine analysis, Trac - Trends in Anal. Chem., 1999, 18, 577 – 584. [114] G. Bagur, M. Sánchez-Viñas, D. Gázquez, M. Ortega, R. Romero, Estimation of the uncertainty associated with the standard addition methodology when a matrix effect is Talanta, 2005, 66, 1168 – 1174. [115] E. Hund, D.L. Massart, J. Smeyers-Verbeke, Comparison of different approaches to estimate the uncertainty of a liquid chromatographic assay, Anal. Chim. Acta, 2003, [116] A. Maroto, J. Riu, R. Boqué, Estimating uncertainties of analytical results using information from the validation process, Anal. Chim. Acta, 1999, 391, 173 – 185. [117] A. Díaz, L. Vázquez, F. Ventura, M.T. Galceran, Estimation of measurement uncertainty for the determination of nonylphenol in water using solid-phase extraction and solid-phase microextraction procedures, Anal. Chim. Acta, 2004, 506, [118] J. O. De Beer, P. Baten, C. Nsengyumva and J. Smeyers-Verbeke, Measurement uncertainty from validation and duplicate analysis results in HPLC analysis of multivitamin preparations and nutrients with different galenic J. Pharm. Biomed. Anal., 2003, 32, 767 – 811. [119] A. Gustavo González, M. Ángeles Herrador and Agustín G. Asuero, Practical digest for evaluating the uncertainty of analytical assays from validation data according to the LGC/VAM protocol, Talanta, 2005, 65, 1022 – 1030. [120] G.T. Wernimont, Use of Statistics to Develop and Evaluate Analytical Methods, Association of American Chemistry, Arlington, VA, 1985. [121] Analytical Method Committee, Uncertainty of measurement: implications of its use in Analyst, 1995, 120 (9), 2303 – 2308. [122] ISO/TS 21748, Lignes directrices relatives à l’utilisation d’estimations de la répétabilité, de la reproductibilité et de la justesse dans l’évaluation de l’incertitude de mesure, Traduction de la version en anglais de 2003, Spécification Technique ISO, [123] ISO/IEC Standards 5725-1, Accuracy (trueness and precision) of measurement methods and results, Part 1: General principles and definitions, ISO Geneva, 1994. [124] ISO/IEC Standards 5725-3, Accuracy (trueness and precision) of measurement methods and results, Part 3: General principles and definitions, ISO Geneva, 1994. [125] S. Kuttatharmmakul, D. L. Massart, J. Smeyers-Verbeke, Comparison of alternative Anal. Chim. Acta, 1999, 391, 203 – 225. [126] B. A. Rofman, S. F. Kulaga, M. A. Gabriel, B. Thiyagarajan, J. F. Nancarrow, W. B. Abrams, Multiclinic evaluation of timolol in the treatment of mild-to-moderate Hypertension 1980, 2, 643 – 648. [127] J. A. Franciosa, E. D. Freis, J. Conway, Antihypertensive and hemodynamic properties of the new beta adrenergic blocking agent timolol, Circulation 1973, 48, 118 – 124. [128] W. H. Frishman, C. D. Furberg, W. T. Friedewald, β-adrenergic blockade for survivors of acute myocardial infarction, N. Eng. J. Med. 1984, 310, 830 – 37. [129] The International Collaborative Study Group, Reduction of infarct size with the early use of timolol in acute myocardial infarction, N. Eng. J. Med. 1984, 310, 9 –15. [130] D.J. Mazzo, A.E. Loper, Timolol maleate in Analytical Profiles of Drug Substances, [131] K. Dickstein, R. Hapnes, T. Aarsland, Comparison of aqueous and gellan ophtalmic timolol with placebo on the 24-hour heart rate response in patients on treatment for Am. J. Ophtalmol., 2001, 132, 626 – 631. [132] W. P. Boger, The treatment of glaucoma: role of β-blocking agents, Drugs 1979, 18, [133] Sifavitor s.p.a., - Casaletto Lodigiano, Italy, Certificat d’analyse. [134] Direction Européenne de la qualité du médicament (DEQM), Conseil de l’Europe, Strasbourg, France, Certificat d’analyse. [135] S. P. Kulkarni, P. D. Amin, Stability indicating HPTLC determination of timolol maleate as bulk drug and in pharmaceutical preparations, J. Pharm. Biomed. Anal., [136] M. Eichelbaum and A.G. Gross, Stereochemical aspects of drug and disposition in Advances in drug research, vol. 28, Academic Press Limited, Londres, Angleterre, [137] K.M. Rentsch, The importance of stereoselective determination of drugs in the clinical laboratory, J. Biochem. Biophys. Methods, 2002, 54, 1 – 9. [138] A.R. Cushny, Biological relations of optically isomeric substances, Baillière, Tindall [139] G. Blaschke, H.P. Kraft, K. Fickentscher, F. Kölher, Chromatographic separation of racemic thalidomide and teratogenic activity of its enantiomers (author's translation), Arzneimittel Forschung, 1979, 29, 1640 – 1642. [140] G. Blaschke, H.P. Kraft, H. Markgraf, Chromatographische Racemattrennung des Thalidomids und anderer Glutarimid- Derivate, Chem. Ber., 1980, 113, 2318 – 2322. [141] A Ceccato, Séparation énantiomérique de médicaments par chromatographie liquide haute performance au moyen de phases stationnaires chirales, Thèse présentée en vue de l’obtention du grade de Docteur en Sciences Pharmaceutiques, Université de Liège, [142] S. Mason, The origin of chirality in nature, Trends Pharmacol. Sci., 1986, 7, 20 – 23. [143] P. A. Lehmann, Stereoisomerism and drug action, Trends Pharmacol. Sci., 1986, 7, [144] E. J. Ariëns, Stereoselectivity in the action of drugs, Pharmacology & Toxicology, [145] D. F. Smith, The stereoselectivity of drug action, Pharmacology & Toxicology, 1989, [146] F. Jamali, R. Mehvar, F.M. Pasutto, Enantioselective aspects of drug action and disposition: Therapeutic Pitfalls, J. Pharmaceut. Sci., 1989, 78, 695 – 715. [147] B. Waldeck, Three-dimensional pharmacology, a subject ranging from ignorance to Pharmacology & Toxicology, 2003, 93, 203 – 210. [148] W. H. De Camp, the FDA perspective on the development of stereoisomers, Chirality, [149] N. R. Srinivas, R. H. Barbhaiya, K.K. Midha, Enantiomeric drug development: Issues, considerations, and regulatory requirements, J. Pharmaceut. Sci., 2001, 90, 1205 – [150] J.A. Tobert, V.J. Cirillo, G. Hitzenberg, I. James, J. Pryor, T. Cook, A. Buntinx, I.B. Holmes, P.M. Lutterbeck, Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio, Clin. Pharmacol. Ther., 1981, 29, 344 – 350. [151] E. H. Blaine, G.M. Fanelli, J.D. Irvin, J.A. Tobert, R.O. Davies, Enantiomers of indacrinone: A new approach to producing an isouricemic diuretic, Clin. Exp. [A], 1982, 4, 161 – 176. [152] P.H. Vlasses, H.H. Rotmensch, B.N. Swanson, J.D. Irvin, C.L. Johnson, R.K. Ferguson, Indacrinone: natriuretic and uricosuric effects of various ratios of enantiomers in healthy men, Pharmacotherapy, 1984, 4, 272 – 277. [153] A.K. Jain, R. Michael, J.R. Ryan, F.G. McMahon, Antihypertensive and biochemical effects of indacrinone enantiomers, Pharmacotherapy, 1984, 4, 278 – 283. [154] B. Feibush, N. Grinberg, The History of Enantiomeric Resolution in Chromatographic Separations, édité par M. Zief et L.J. Crane, Chromatographic Sciences Series, [155] W. H. De Camp, Chiral drugs: the FDA perspective on manufacturing and control, J. Pharm. Biomed. Anal., 1993, 11, 1167 – 1172. [156] E. L. Eliel, S. H. Wilen, Stéréochimie des composés organiques, Editions Lavoisier, [157] S. Allenmark in Chromatographic enantioseparation, methods and applications, 2ème édition, Ellis Horwood, Chichester, 1991. [158] M. Lämmerhofer, Chiral separations by capillary electromigration techniques in nonaqueous media: I. Enantioselective nonaqueous capillary electrophoresis, J. [159] M. Lämmerhofer, Chiral separations by capillary electromigration techniques in nonaqueous media: II. Enantioselective nonaqueous capillary electrochromatography, J. Chromatogr. A, 2005, 1068, 31 – 57. [160] J. Hermansson, Direct liquid chromatographic resolution of racemic drugs using α1- acid glycoprotein as the chiral stationary phase, J. Chromatogr., 1983, 269, 71 – 80. [161] J. Hermansson, Enantiomeric separation of drugs and related compounds based on their interaction with α1-acid glycoprotein, Trends in Anal. Chem., 1989, 8, 251 – 259. [162] T. Miwa, T. Miyakawa, M. K. Y. Miyake, Application of an ovomucoid-conjugated column for the optical resolution of some pharmaceutically important compounds, J. Chromatogr., 1987, 408, 316 – 322. [163] I. Marle, P. Erlandsson, L. Hansson, R. Isaksson, C. Pettersson, G. Pettersson, Separation of enantiomers using cellulase (CBH I) silica as a chiral stationary phase, J. Chromatogr., 1991, 586, 233 – 248. [164] I. Marle, S. Jönsson, R. Isaksson, C. Pettersson, G. Pettersson, Chiral stationary phases based on intact and fragmented cellobiohydrolase I immobilized on silica, J. Chromatogr., 1993, 648, 333 – 347. [165] E. Domenici, C. Bertucci, P. Salvadori, S. Motellier, I.W. Wainer, Immobilized serum albumin: rapid HPLC probe of stereoselective protein-binding interactions, Chirality, [166] S. Allenmark, B. Bomgren, H. Borén, Direct liquid chromatographic separation of enantiomers on immobilized protein stationary phases: III. Optical resolution of a series of N-aroyl D,L-amino acids by high-performance liquid chromatography on bovine serum albumin covalently bound to silica, J. Chromatogr., 1983, 264, 63 – 68. [167] A. Ceccato, Ph. Hubert, J. Crommen, Direct liquid chromatographic enantioseparation of sotalol and other β-blockers using an α1-acid glycoprotein-based chiral stationary J Chromatogr. A, 1997, 760, 193 – 203. [168] A. Ceccato, Ph. Hubert, P. de Tullio, J.-F. Liégeois, A. Felikidis, J. Géczy, J. Crommen, Enantiomeric separation of pirlindole by liquid chromatography using different types of chiral stationary phases, J. Pharm. Biomed. Anal., 1998, 18, [169] A. Berthod, T. Ling Xiao, Y. Liu, W. S. Jenks, D. W. Armstrong, Separation of chiral sulfoxides by liquid chromatography using macrocyclic glycopeptide chiral stationary J. Chromatogr. A, 2002, 955, 53 – 69. [170] Z. Bosáková, I. Klouková, E. Tesaová, Study of the stability of promethazine enantiomers by liquid chromatography using a vancomycin-bonded chiral stationary J. Chromatogr. B: Analytical Technologies in the Biomedical and Life Sciences, [171] K. H. Ekborg-Ott, X. Wang, D. W. Armstrong, Effect of Selector Coverage and Mobile Phase Composition on Enantiomeric Separations with Ristocetin A Chiral Microchemical Journal, 1999, 62, 26 – 49. [172] C. Rosini, P. Altemura, D. Pini, C. Bertucci, G. Zullino, P. Salvadori, Cinchona alkaloids for preparing new, easily accessible chiral stationary phases : II. Resolution of binaphthol derivatives on silica-supported quinine, J. Chromatogr. A, 1985, 348, 79 [173] A. Mandl, L. Nicoletti, M. Lämmerhofer, W. Lindner, Quinine- versus carbamoylated quinine-based chiral anion exchangers: A comparison regarding enantioselectivity for and other chiral acids, J. Chromatogr. A, 1999, 858, 1 – 11. [174] A. Ceccato, B. Toussaint, P. Chiap, Ph. Hubert, J. Crommen, Enantioselective determination of oxprenolol in human plasma using dialysis coupled on-line to reversed-phase chiral liquid chromatography, J. Pharm. Biomed. Anal., 1997, 15, 1365 [175] G. Félix, T. Zhang, Chiral packing materials for high-performance liquid chromatographic resolution of enantiomers based on substituted branched polysaccharides coated on silica gel, J. Chromatogr. A, 1993, 639, 141 – 149. [176] Y. Okamoto, Y. Kaida, R. Aburatani, K. Hatada, Optical resolution of amino acid high-performance liquid chromatography on tris(phenylcarbamate)s of cellulose and amylase, J. Chromatogr. A, 1989, 477, 367 – 376. [177] Y. Kaida, Y. Okamoto, Optical resolution by high-performance liquid chromatography on benzylcarbamates of cellulose and amylase, J. Chromatogr. A, 1993, 641, 267 – [178] Y. Okamoto, Y. Kaida, Resolution by high-performance liquid chromatography using polysaccharide carbamates and benzoates as chiral stationary phases, J. Chromatogr. A, 1994, 666, 403 – 419. [179] E. Yashima, H. Fukaya, Y. Okamoto, 3,5-Dimethylphenylcarbamates of cellulose and amylose regioselectively bonded to silica gel as chiral stationary phases for high- J. Chromatogr. A, 1994, 677, 11 – 19. [180] B. Chankvetadze, E. Yashima, Y. Okamoto, Dimethyl-, dichloro- and amylose as chiral stationary phases for high- J. Chromatogr. A, 1995, 694, 101 – 109. [181] J. Whatley, Enantiomeric separation by packed column chiral supercritical fluid J. Chromatogr. A, 1995, 697, 251 - 255. [182] M. S. Villeneuve, R. J. Anderegg, Analytical supercritical fluid chromatography using fully automated column and modifier selection valves for the rapid development of J. Chromatogr. A, 1998, 826, 217 – 225. [183] B. Chankvetadze, L. Chankvetadze, S. Sidamonidze, E. Kasashima, E. Yashima and Y. Okamoto, 3-Fluoro-, 3-chloro- and 3-bromo-5-methylphenylcarbamates of cellulose and amylose as chiral stationary phases for high-performance liquid J. Chromatogr. A, 1997, 787, 67 – 77. [184] Y. Okamoto, J. Noguchi, E. Yashima, Enantioseparation on 3,5-dichloro- and 3,5- dimethylphenylcarbamates of polysaccharides as chiral stationary phases for high- Reactive and Functional Polymers, 1998, 37, 183 [185] M. Girod, B. Chankvetadze, G. Blaschke, Enantioseparations in non-aqueous capillary electrochromatography using polysaccharide type chiral stationary phases, J. A, 2000, 887, 439 – 455. [186] M. Liu, S-L. Da, Y.-Q. Feng, L.-S. Li, Study on the preparation method and performance of a new β-cyclodextrin bonded silica stationary phase for liquid Anal. Chim. Acta, 2005, 533, 89 – 95. [187] X. Han, T. Yao, Y. Liu, R. C. Larock, D. W. Armstrong, Separation of chiral furan derivatives by liquid chromatography using cyclodextrin-based chiral stationary J. Chromatogr. A, 2005, 1063, 111 – 120. [188] D.W. Armstrong, T. J. Ward, R .D. Armstrong, T. E. Beesley, Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes, Science, [189] N. Thuaud, B. Sebille, Structural factors affecting the enantiomeric separation of barbiturates and thiobarbiturates with a chiral side-chain by various β-cyclodextrin supports. Effects of the presence of hydroxypropyl substituents on the chiral selector, J. Chromatogr. A, 1994, 685, 15 – 20. [190] J. Zulkowski, R. Nowakowski, J. Liq. Chromatogr. 1989, 12, 1545 – 1569. [191] W.A. Koning, D. Ichein, T. Runge, B. Pfaffenberg, P. Ludwig and H. Huhnerfuss, Gas chromatographic enantiomer separation of agrochemicals using modified J. High Resolut. Chromatogr. 14 (1991), p. 530 – 536. [192] B. Blessington, N. Crabb, J. O'Sullivan., Chiral high-performance liquid chromatographic studies of 2-(4-chloro-2-methylphenoxy)propanoic acid, J. Chromatogr. 1987, 396, 177 – 182. [193] B. Chankvetadze, M. Saito, E. Yashima, Y. Okamoto, Enantioseparation using selected polysaccharides as chiral buffer additives in capillary electrophoresis, J. A, 1997, 773, 331 – 338. [194] V. Piette, M. Fillet, W. Lindner, J. Crommen, Non-aqueous capillary electrophoretic enantioseparation of N-derivatized amino acids using cinchona alkaloids and derivatives as chiral counter-ions, J. Chromatogr. A, 2000, 875, 353 – 360. [195] E. De Lorenzi, G. Massolini, Riboflavin binding proteins as chiral selectors in HPLC CE, Pharmaceutical Science & Technology Today, 1999, 2, 352 – 364. [196] J. Haginaka, Enantiomer separation of drugs by capillary electrophoresis using proteins as chiral selectors, J. Chromatogr. A, 2000, 875, 235 – 254. [197] M. C. Millot, Separation of drug enantiomers by liquid chromatography and capillary immobilized proteins as chiral selectors, J. Chromatogr. B, [198] Y. Tanaka, S. Terabe, Recent advances in enantiomer separations by affinity capillary electrophoresis using proteins and peptides, J. Biochem. Biophysic. Meth., 2001, 48, [199] S. Fanali, Identification of chiral drug isomers by capillary electrophoresis, J. [200] K. D. Altria, M. A. Kelly, B. J. Clark, Current applications in the analysis of pharmaceuticals by capillary electrophoresis. II, TrAC Trends in Anal. Chem., 1998, [201] T. J. Ward, A. B. Farris III, Chiral separations using the macrocyclic antibiotics: a J. Chromatogr. A, 2001, 906, 73 – 89. [202] M. Fillet, Séparation énantiomérique de médicaments par électrophorèse capillaire à l’aide de cyclodextrines, Thèse présentée en vue de l’obtention du grade de Docteur en Sciences Pharmaceutiques, Université de Liège, 1997 – 1998. [203] J. Snopek, I. Jelínek, E. Smolková-Keulemansová, Use of cyclodextrins in isotachophoresis : IV. The influence of cyclodextrins on the chiral resolution of ephedrine alkaloid enantiomers, J. Chromatogr. A, 1988, 438, 211 – 218. [204] M. Fillet, I. Bechet, Ph. Hubert, J. Crommen, Resolution improvement by use of carboxymethyl-β-cyclodextrin as chiral additive for the enantiomeric separation of basic drugs by capillary electrophoresis, J. Pharm. Biomed. Anal., 1996, 14, 1107 – [205] M. Fillet, L. Fotsing, J. Crommen, Enantioseparation of uncharged compounds by capillary electrophoresis using mixtures of anionic and neutral β-cyclodextrin J. Chromatogr. A, 1998, 817, 113 – 119. [206] M. Fillet, Ph. Hubert, J. Crommen, Enantiomeric separations of drugs using mixtures of charged and neutral cyclodextrins, J. Chromatogr. A, 2000, 875, 123 – [207] A. M. Abushoffa, M. Fillet, Ph. Hubert, J. Crommen, Prediction of selectivity for enantiomeric separations of uncharged compounds by capillary electrophoresis involving dual cyclodextrin systems, J. Chromatogr. A, 2002, 948, 321 – 329. [208] A. M. Abushoffa, M. Fillet, A.-C. Servais, Ph. Hubert, J. Crommen, Enhancement of resolution in the separation of uncharged compounds using mixtures of oppositely charged cyclodextrins in capillary electrophoresis, Electrophoresis, 2003, [209] Pharmacopée Européenne, 5ème édition, 2004, Conseil de l’Europe, Strasbourg, [210] J. Crommen, “Capillary electrophoresis”, Comett Euro training course, Montpellier, [211] C.L. Copper, J. B. Davis, R.O. Cole, M.J. Sepaniak, Separations of derivatized amino- acid enantiomers by cyclodextrin-modified capillary electrophoresis: mechanistic and molecular modelling studies, Electrophoresis, 1994, 15, 785 – 792. [212] D. Belder, G. Schomburg, Chiral separations of basic and acidic compounds in modified capillaries using cyclodextrin-modified capillary zone electrophoresis, J. Chromatogr., 1994, 666, 351 – 365. [213] I.Z. Atamna, H.J. Issaq, G.M. Muschik, G.M. Janimi, Optimization of resolution in capillary zone electrophoresis: combined effect of applied voltage and buffer J. Chromatogr., 1991, 588, 315 – 320. [214] H. Poppe, Overloading and interaction phenomena in electrophoretic separations, Anal. Chem., 1992, 64, 1908 – 1919. [215] H. Y. Aboul-Enein, M. R. Islam, Direct separation and optimization of timolol enantiomers on a cellulose tris-3,5-dimethylphenylcarbamate high-performance liquid chromatographic chiral stationary phase, J. Chromatogr. A, 1990, 511, 109 – 114. [216] B. Toussaint, B. Streel, A. Ceccato, Ph. Hubert, J. Crommen, Determination of the enantiomers of 3-tert.-butylamino-1,2-propanediol by high-performance liquid chromatography using mass spectrometric detection, J Chromatogr. A, 2000, 896, [217] G. M. Hanna, C. A. Lau-Cam, Determination of the optical purity of timolol maleate by proton nuclear-magnetic-resonance spectroscopy with a chiral Pr(III) shift-reagent, J. Pharm. Biomed. Anal., 1995, 13, 1313 – 1319. [218] P. M. Lacroix, R. W. Sears, B. A. Dawson, D. B. Black, Canadian Bureau of Drug [219] P. M. Lacroix, R. W. Sears, B. A. Dawson, D. B. Black, HPLC and NMR methods for the quantitation of the (R)-enantiomer in (-)-(S)-timolol maleate drug raw-materials, Chirality, 1994, 6, 484 – 491. [220] G.M. Hanna, Nonequivalence behavior studies for the direct determination of enantiomeric purity and absolute configuration of timolol by NMR, Pharmazie 2004, [221] M. X. Huo, Determination of related substances in timolol maleate and its eye drops by reversed-phase ion-pair HPLC, Yaowu Fenxi Zazhi, 2000, 20, 181 – 184. [222] D. J. Mazzo, P. A. Snyder, High-performance liquid chromatography of timolol and potential degradates on dynamically modified silica, J. Chromatogr., 1988, 438, 85 – [223] T. V. Olah, J. D. Gilbert, A. Barrish, Determination of the β-adrenergic blocker timolol in plasma by liquid chromatography—atmospheric pressure chemical ionization mass spectrometry, J. Pharm. Biomed. Anal., 1993, 11, 157 – 163. [224] D. J. Mazzo, Simultaneous determination of maleic acid and timolol by high- J. Chromatogr., 1984, 299, 503 – 507. [225] K. Kubota, H. Nakamura, E. Koyama, T. Yamada, K. Kikuchi, T. Ishizaki, J. Chromatogr. Biomed. Appl., 1990, 533, 255 – 263. [226] M. S. Lennard, S. Parkin, J. Chromatogr. Biomed. Appl., 1985, 338, 249 – 252. [227] Manuel d’instruction pour Chiralcel OD-H, Daicel Chemical Industries, LTD. [228] G.E.P. Box, D.W. Behnken, Some new three level designs, Technometrics, 1960, 2, [229] B. Boulanger, Notes de cours intitulé « d’optimisation des méthodes analytiques », année académique 2000 – 2001. [230] F.H. Walters, H. Qui, The use of a Box-Behnken three factor design to study the paper chromatographic separation of several amino acid hydroxamates, Analytical Letter, [231] R. Ragonese, M. Macka, J. Hughes, P. Petocz, The use of the Box-Behnken experimental design in the optimisation and robustness testing of a capillary electrophoresis method for the analysis of ethambutol hydrochloride in pharmaceutical J. Pharm. Biomed. Appl., 2002, 27, 995 – 1007. [232] J. Miller, Chromatography in Concepts and Contrasts, John Wiley and Sons, New [233] D. Hoffman, R. Kringle, Two-sided tolerance intervals for balanced and unbalanced random effects models, Journal of Biopharmaceutical Statistics, 2005, 15, 283 – 293. [234] United States Pharmacopoeia XXII, general information <1225>, The United States Pharmacopoeia Inc., Rockville, MD, USA, p.1710, 1990. [235] ICH: Q2B Validation of Analytical Procedures: Methodology, Guidance for Industry, [236] L. Cuadros-Rodríguez, A. M. García-Campaña, E. Almansa-López, F. J. Ege- González, M. L. Castro Cano, A. G. Frenich, J. L. Martínez-Vidal, Anal. Chim. Acta [237] Food and Drug Administration: International Conference on Harmonization: guideline on validation of analytical procedures: definitions and terminology, Fed. Regist., 1995, [238] J. Van Loco, M. Elskens, C. Croux, H. Beernaert, Linearity of calibration curves: use and misuse of the correlation coefficient, Accred. Qual. Assur., 2002, 7, 281 – 285. [239] D.B. Hibbert, Further comments on the (miss-)use of r for testing the linearity of functions, Accred. Qual. Assur., 2005, 10, 300 – 301. [240] Miller and Miller, Statistics and Chemometrics for Analytical Chemistry, 4th ed., [241] A.G. Gonzalez, A.G. Asuero, Computational program for validating methods, Fresenius J. Anal. Chem., 1993, 346, 885 – 887. [242] Food and Drug Administration, Process Analytical Technology (PAT) Initiative, 2004, [243] ICH Topic Q2B Validation of analytical procedures: Methodology. Step 4, consensus guideline, the International Conference on Harmonization of Technical Requirements for registration of Pharmaceuticals for human use, November 6, 1996. [244] Y. Vander Heyden, K. Luypaert, C. Hartman, D.L. Massart, J. Hoogmartens, J. de Beer, Ruggedness tests on the high-performance liquid chromatography assay of the United States Pharmacopeia XXII for tetracycline hydrochloride. A comparison of experimental designs and statistical interpretations, Anal. Chim. Acta, 1995, 312, 245 [245] P. Dehouck, Y. Vander Heyden, J. Smeyers-Verbeke, D.L. Massart, R.D. Marini, P. Chiap, Ph. Hubert, J. Crommen, W. Van de Wauw,J. De Beer, R. Cox, G. Mathieu, J.C. Reepmeyer, B. Voigt, O. Estevenon, A. Nicolas, A. Van Schepdael, E. Adams, J. Hoogmartens, Interlaboratory study of a liquid chromatography method for erythromycin: determination of uncertainty J. Chromatogr. A, 2003, 1010, 63 – 74. [246] F.E. Grubbs, Procedures for detecting outlying observations in samples, Technometrics, 1969, 11, 1 – 21. [247] P.C. Kelly, Outlier detection in collaborative studies, J. Assoc. Off. Anal. Chem., 1990, [248] R. H. Albert, Outliers in collaborative studies: coping with uncertainty, J. Assoc. Off. Chem., 1986, 69, 429 – 432. [249] A. Rizzi, Fundamental aspects of chiral separations by capillary electrophoresis, Electrophoresis, 2001, 22, 3079 – 3106. [250] J.B. Vincent, G. Vigh, Nonaqueous capillary electrophoretic separation of enantiomers using the single-isomer heptakis(2,3-diacetyl-6-sulfato)-beta-cyclodextrin as chiral J. Chromatogr. A, 1998, 816, 233 – 241. [251] M. Tacker, P. Glukhovskiy, H. Cai, G. Vigh, Nonaqueous capillary electrophoretic separation of basic enantiomers using heptakis(2,3-dimethyl-6-sulfato)-beta- Electrophoresis, ,1999, 20, 2794 – 2798. [252] W. Zhu, G. Vigh, Enantiomer separations by nonaqueous capillary electrophoresis octakis(2,3-diacetyl-6-sulfato)-gamma-cyclodextrin, J. Chromatogr. A, 2000, [253] M.B. Busby, O. Maldonado, G. Vigh, Nonaqueous capillary electrophoretic separation of basic enantiomers using octakis(2,3-O-dimethyl-6-O-sulfo)-gamma-cyclodextrin, a new, single-isomer chiral resolving agent, Electrophoresis, 2002, 23, 456 – 461. [254] A.-C. Servais, M. Fillet, A.M. Abushoffa, P. Hubert, J. Crommen, Synergistic effects of ion-pairing in the enantiomeric separation of basic compounds with cyclodextrin derivatives in nonaqueous capillary electrophoresis, Electrophoresis, 2003, 24, 363 – [255] A.-C. Servais, M. Fillet, P. Chiap, W. Dewé, Ph. Hubert, J. Crommen, Enantiomeric separation of basic compounds usin heptakis(2,3-di-O-methyl-6-O-sulfo)-beta- cyclodextrin in combination with potassium camphorsulfonate in nonaqueous capillary electrophoresis: Optimization by means of an experimental design, Electrophoresis, [256] A. Aumatell, R. J. Wells, D. K. Y. Wong, Enantiomeric differentiation of a wide-range of pharmacologically active substances by capillary electrophoresis using modified J. Chromatogr. A, 1994, 686, 293 – 307. [257] A. Aumatell, R. J. Wells, Enantiomeric differentiation of a wide-range of pharmacologically active substances by cyclodextrin-modified micellar electrokinetic capillary chromatography using a bile-salt, J. Chromatogr. A, 1994, 688, 329 – 337. [258] K. D. Altria, Improved performance in capillary electrophoresis using internal LC GC Europe, 2002, 15, 588 – 594. [259] H.-Y. Liu, W.-H. Ding, Determination of homologues of quaternary ammonium surfactants by capillary electrophoresis using indirect UV detection, J. Chromatogr. A, [260] Ph. Hubert, J.-J. Nguyen-Huu, B. Boulanger, E. Chapuzet, P. Chiap, N. Cohen, P.-A. Compagnon, W. Dewé, M. Feinberg, M. Lallier, M. Laurentie, N. Mercier, G. Muzard, C. Nivet, L. Valat, Harmonization of strategies for the validation of procedures - A SFSTP proposal - part I, J. Pharm. Biomed. Anal., 2004, 36, 579 – 586. [261] J. M. Bland, D. G. Altman, Statistical methods for assessing agreement between two methods of clinical measurement, The Lancet, 1986, 307 – 310. [262] H. Petersen, D. Stöckl, O. Blaabjerg, B. Pedersen, E. Birkemose, L. Thienpont, J. F. Lassen, J. Kjeldsen, Graphical interpretation of analytical data from comparison of a field method with a Reference Method by use of difference plots, Clinical Chemistry, [263] C. Perrin, H. Fabre, D.L. Massart, Y. Vander Heyden, Influence of peak measurement parameters on the quality of chiral electrophoretic separations, Electrophoresis, 2003, [264] K. D. Altria, N. G. Clayton, R. C. Harden, J. V. Makwana, M. J. Portsmouth, An inter- company cross-validation exercise on capillary electrophoresis testing of dose uniformity of paracetamol content in formulations, Chromatographia 1995, 40, 47 – [265] A. Amini, B. Wiersma, D. Westerlund, U. Paulsen-Sörman, Determination of the enantiomeric purity of S-ropivacaine by capillary electrophoresis with methyl-beta- cyclodextrin as chiral selector using conventional and complete filling techniques Eur. J. Pharm. Sc. 1999, 9, 17 – 24. [266] B. X. Mayer, M. Müller, K. Altria, Long-term analyses with capillary electrophoresis, LC GC Europe, 2001, 14, 19 – 26. [267] F.E. Satterthwaite, An approximate distribution of estimates of variance components, Biometrics Bull, 1946, 2, 110 114.
[268] S.R. Searle, G. Casella, C.E. McCulloch in Variance components, Wiley, New-York, [269] W. Horwitz, L.R. Kamps and K.W. Boyer, Quality assurance in the analysis of foods J. Assoc. off. Anal. Chem. 1980, 63, 1344 – 1354.

Source: http://bictel.ulg.ac.be/ETD-db/collection/submitted/ULgetd-07032007-221300/unrestricted/19_ReferencesBibliographiques.pdf

Bwt1092006.qxd

B I O T E C H ’ S M O S T R E S P E C T E D N E W S S O U R C E F O R O V E R 1 5 Y E A R S T H E D A I L Y B I O T E C H N O L O G Y N E W S P A P E R KAI’s PKC Program Nabs Tioga’s Series A Round: $24M $340M Deal With Sankyo For Phase IIb Trial Of IBS Drug KAI Pharmaceuticals Inc. signed a potential $340 mil-Six months after licensing a promising early stagelion dea

Microsoft word - ishsko centre medical forms 2012.docx

IIIIIIIIIIIIIIIIIII barrack yard I westport I county mayo I ireland I tel: 098-26200 I fax: 098-26202 I www.mercuryfreeentistry.eu | ishskoinfo@ gmail.com | Evelien Van Amerongen (founder, holistic dentist) CONSENT TO TREATMENT I voluntarily consent to receive dental and complimentary that all services must be paid for at the time of the visit , health care services

Copyright © 2010-2014 Pharmacy Pills Pdf